ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $817.37 million. The enterprise value is $590.25 million.
| Market Cap | 817.37M |
| Enterprise Value | 590.25M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 96.50 million shares outstanding. The number of shares has increased by 138.30% in one year.
| Shares Outstanding | 96.50M |
| Shares Change (YoY) | +138.30% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 27.45% |
| Owned by Institutions (%) | 65.55% |
| Float | 37.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27,277.79 |
| Forward PS | n/a |
| PB Ratio | 3.55 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19,674.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 96.92, with a Debt / Equity ratio of 0.00.
| Current Ratio | 96.92 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.20% and return on invested capital (ROIC) is -29.23%.
| Return on Equity (ROE) | -22.20% |
| Return on Assets (ROA) | -21.50% |
| Return on Capital (ROIC) | -29.23% |
| Revenue Per Employee | $1,250 |
| Profits Per Employee | -$2.27M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.03% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +23.03% |
| 50-Day Moving Average | 8.64 |
| 200-Day Moving Average | 6.34 |
| Relative Strength Index (RSI) | 41.03 |
| Average Volume (30 Days) | 692,087 |
Short Selling Information
The latest short interest is 5.50 million, so 5.70% of the outstanding shares have been sold short.
| Short Interest | 5.50M |
| Short Previous Month | 4.25M |
| Short % of Shares Out | 5.70% |
| Short % of Float | 14.78% |
| Short Ratio (days to cover) | 5.69 |
Income Statement
In the last 12 months, SPRY had revenue of $30,000 and -$54.37 million in losses. Loss per share was -$0.57.
| Revenue | 30,000 |
| Gross Profit | 30,000 |
| Operating Income | -67.52M |
| Pretax Income | -54.37M |
| Net Income | -54.37M |
| EBITDA | -54.29M |
| EBIT | -54.37M |
| Loss Per Share | -$0.57 |
Balance Sheet
The company has $228.36 million in cash and $274,000 in debt, giving a net cash position of $228.09 million or $2.36 per share.
| Cash & Cash Equivalents | 228.36M |
| Total Debt | 274,000 |
| Net Cash | 228.09M |
| Net Cash Per Share | $2.36 |
| Equity / Book Value | 230.76M |
| Book Value Per Share | 2.39 |
| Working Capital | 229.34M |
Cash Flow
In the last 12 months, operating cash flow was -$59.27 million and capital expenditures -$175,000, giving a free cash flow of -$59.44 million.
| Operating Cash Flow | -59.27M |
| Capital Expenditures | -175,000 |
| Free Cash Flow | -59.44M |
| FCF Per Share | -$0.62 |
Margins
Gross margin is 100.00%, with operating and profit margins of -225,066.67% and -181,216.67%.
| Gross Margin | 100.00% |
| Operating Margin | -225,066.67% |
| Pretax Margin | -181,216.67% |
| Profit Margin | -181,216.67% |
| EBITDA Margin | -180,973.33% |
| EBIT Margin | -181,216.67% |
| FCF Margin | -198,136.67% |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -138.30% |
| Shareholder Yield | -138.30% |
| Earnings Yield | -6.64% |
| FCF Yield | -7.26% |
Analyst Forecast
The average price target for SPRY is $18.50, which is 118.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.50 |
| Price Target Difference | 118.42% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 537.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 201.85 and a Piotroski F-Score of 2.
| Altman Z-Score | 201.85 |
| Piotroski F-Score | 2 |